Joint inflammation increases glucosamine levels attained in synovial fluid following oral administration of glucosamine hydrochloride.

The research article discusses a study where the concentration of glucosamine in the synovial fluid of equine (horse) joints was observed after oral administration of glucosamine hydrochloride. The study found that inflamed joints had significantly higher concentrations of glucosamine than healthy joints.

Study Design and Methods

• Eight adult horses were studied over the course of four weeks. The study was designed to compare glucosamine levels in normal and inflamed horse joints following the oral administration of glucosamine hydrochloride.
• The horses were treated with glucosamine hydrochloride or a placebo through nasogastric (NG) intubation or intravenous injection. Additionally, inflammation was induced in the joints by injecting the radiocarpal (wrist) joints with Escherichia coli lipopolysaccharide (LPS).
• Plasma and synovial fluid samples were collected at intervals before and after dosing for analysis. The glucosamine levels in these samples were measured using Liquid Chromatography Electrospray Tandem Mass Spectrometry (LC-ESI/MS/MS), a technique used for identifying and quantifying chemicals in a sample.
• Clinicopathological evaluation of the synovial fluid parameters, including white blood cell (WBC) count and total protein (TP) analyses, was performed to study the inflammatory response to injected LPS.

Results and Conclusion

• The results showed that there were no significant differences in baseline levels of WBC and TP in the synovial fluid among the horses at any stage of the study.
• However, these parameters did increase significantly after the injection of LPS, suggesting that inflammation had been successfully induced in the joints.
• Most importantly, the study found that the synovial fluid glucosamine levels were significantly higher in inflamed joints compared to healthy joints. The maximum glucosamine levels in the inflamed joints were over four times higher than those in healthy joints; however, these increased glucosamine levels did not appear to impact the parameters of inflammation examined in the study.
• The authors concluded that joint inflammation leads to significantly higher synovial fluid glucosamine concentrations compared to levels in healthy joints following oral administration of glucosamine hydrochloride. Nonetheless, the researchers point out that the therapeutic effect of these higher glucosamine levels on joint tissues remains unclear and calls for further investigation.